LCD-DL40060
Document details
Summary
The proposed Local Coverage Determination (LCD) for MolDX molecular testing could significantly influence billing practices for solid organ allograft rejection assessments. This may lead to improved cNew LCD could reshape billing for organ transplant tests.
Affected specialty
Nephrology alerts →Source document
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=40059&ver=8CLV Intelligence summarizes publicly available federal publications. Not affiliated with or endorsed by any government agency.
Related alerts
1Policy LCD-L35751 · Nephrology
The implementation of LCD for non-invasive peripheral venous vascular and hemodialysis access studies by WPS may lead to an increase in claims for related diagnostic procedures. Providers should ensur
View alert